A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient
Clinical trial NCT05493631 · COMPLETED
Trial details
- NCT number
- NCT05493631
- Sponsor
- GC Biopharma Corp
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2024-12-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.